CN114796047A - Anti-dandruff composition, application of anti-dandruff composition, shampoo and preparation method of shampoo - Google Patents
Anti-dandruff composition, application of anti-dandruff composition, shampoo and preparation method of shampoo Download PDFInfo
- Publication number
- CN114796047A CN114796047A CN202210418946.4A CN202210418946A CN114796047A CN 114796047 A CN114796047 A CN 114796047A CN 202210418946 A CN202210418946 A CN 202210418946A CN 114796047 A CN114796047 A CN 114796047A
- Authority
- CN
- China
- Prior art keywords
- sodium
- extract
- shampoo
- dandruff
- cocoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000001840 Dandruff Diseases 0.000 title claims abstract description 71
- 239000002453 shampoo Substances 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 57
- 210000004761 scalp Anatomy 0.000 claims abstract description 28
- 229920001202 Inulin Polymers 0.000 claims abstract description 26
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 26
- 229940029339 inulin Drugs 0.000 claims abstract description 26
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 23
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims abstract description 15
- 244000064816 Brassica oleracea var. acephala Species 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000220286 Sedum Species 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 14
- -1 hydroxypropyl Chemical group 0.000 claims description 9
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 claims description 8
- 229940073507 cocamidopropyl betaine Drugs 0.000 claims description 8
- 229940057950 sodium laureth sulfate Drugs 0.000 claims description 8
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- 229960005323 phenoxyethanol Drugs 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 6
- 230000002335 preservative effect Effects 0.000 claims description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 6
- 235000010234 sodium benzoate Nutrition 0.000 claims description 6
- 239000004299 sodium benzoate Substances 0.000 claims description 6
- 239000002562 thickening agent Substances 0.000 claims description 6
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- 239000004094 surface-active agent Substances 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 4
- 108010077895 Sarcosine Proteins 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- HWUINYGRRJTXGE-UTLKBRERSA-L disodium;(2s)-2-(dodecanoylamino)pentanedioate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC([O-])=O HWUINYGRRJTXGE-UTLKBRERSA-L 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 3
- 229940083542 sodium Drugs 0.000 claims description 3
- 229940079781 sodium cocoyl glutamate Drugs 0.000 claims description 3
- TUBPSFQENHCYBW-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;2-[bis(2-hydroxyethyl)amino]ethanol Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OCCN(CCO)CCO TUBPSFQENHCYBW-HVDRVSQOSA-N 0.000 claims description 2
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 2
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 claims description 2
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims description 2
- OUNZARDETXBPIX-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)acetic acid Chemical compound CCCCCCCCCCCCOCCOCC(O)=O OUNZARDETXBPIX-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 claims description 2
- ACCAIGJKLCJFHP-UQKRIMTDSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ACCAIGJKLCJFHP-UQKRIMTDSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 2
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 claims description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 2
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 2
- BVTHRGZMQHOCOL-UHFFFAOYSA-N OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO Chemical compound OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO BVTHRGZMQHOCOL-UHFFFAOYSA-N 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 125000003118 aryl group Chemical group 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 229960003993 chlorphenesin Drugs 0.000 claims description 2
- 229940080421 coco glucoside Drugs 0.000 claims description 2
- 229920006037 cross link polymer Polymers 0.000 claims description 2
- 229940073499 decyl glucoside Drugs 0.000 claims description 2
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 2
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 claims description 2
- 229940079779 disodium cocoyl glutamate Drugs 0.000 claims description 2
- 229940079868 disodium laureth sulfosuccinate Drugs 0.000 claims description 2
- 229940079881 disodium lauroamphodiacetate Drugs 0.000 claims description 2
- GLSRFBDXBWZNLH-UHFFFAOYSA-L disodium;2-chloroacetate;2-(4,5-dihydroimidazol-1-yl)ethanol;hydroxide Chemical compound [OH-].[Na+].[Na+].[O-]C(=O)CCl.OCCN1CCN=C1 GLSRFBDXBWZNLH-UHFFFAOYSA-L 0.000 claims description 2
- YGAXLGGEEQLLKV-UHFFFAOYSA-L disodium;4-dodecoxy-4-oxo-2-sulfonatobutanoate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOC(=O)CC(C([O-])=O)S([O-])(=O)=O YGAXLGGEEQLLKV-UHFFFAOYSA-L 0.000 claims description 2
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 claims description 2
- WWYHAQDAMPXWSI-UHFFFAOYSA-N dodecan-1-ol;methane Chemical compound C.CCCCCCCCCCCCO WWYHAQDAMPXWSI-UHFFFAOYSA-N 0.000 claims description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 2
- 229940074046 glyceryl laurate Drugs 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229940001447 lactate Drugs 0.000 claims description 2
- 229940094506 lauryl betaine Drugs 0.000 claims description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 claims description 2
- 229940048848 lauryl glucoside Drugs 0.000 claims description 2
- 229940044591 methyl glucose dioleate Drugs 0.000 claims description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 229960002216 methylparaben Drugs 0.000 claims description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229940049292 n-(3-(dimethylamino)propyl)octadecanamide Drugs 0.000 claims description 2
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 claims description 2
- WWVIUVHFPSALDO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C WWVIUVHFPSALDO-UHFFFAOYSA-N 0.000 claims description 2
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 2
- 229940086539 peg-7 glyceryl cocoate Drugs 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 2
- 108700004121 sarkosyl Proteins 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 229940031688 sodium c14-16 olefin sulfonate Drugs 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 229940096501 sodium cocoamphoacetate Drugs 0.000 claims description 2
- 229940045944 sodium lauroyl glutamate Drugs 0.000 claims description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 2
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 claims description 2
- 229940048109 sodium methyl cocoyl taurate Drugs 0.000 claims description 2
- 229940060304 sodium myristoyl sarcosinate Drugs 0.000 claims description 2
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 claims description 2
- KHCOJQDJOCNUGV-UHFFFAOYSA-M sodium;2-[methyl(tetradecanoyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N(C)CC([O-])=O KHCOJQDJOCNUGV-UHFFFAOYSA-M 0.000 claims description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 2
- 229940048912 triethanolamine cocoyl glutamate Drugs 0.000 claims description 2
- 244000247747 Coptis groenlandica Species 0.000 claims 5
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims 3
- 229940104261 taurate Drugs 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims 1
- KTYVHLCLTPLSGC-UHFFFAOYSA-N amino propanoate Chemical compound CCC(=O)ON KTYVHLCLTPLSGC-UHFFFAOYSA-N 0.000 claims 1
- ZPRZNBBBOYYGJI-UHFFFAOYSA-L disodium;2-[1-[2-(carboxylatomethoxy)ethyl]-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCOCC([O-])=O)CC([O-])=O ZPRZNBBBOYYGJI-UHFFFAOYSA-L 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 claims 1
- GOJYXPWOUJYXJC-UHFFFAOYSA-M sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;hydroxide Chemical compound [OH-].[Na+].CCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O GOJYXPWOUJYXJC-UHFFFAOYSA-M 0.000 claims 1
- 241000218202 Coptis Species 0.000 abstract description 18
- 230000003020 moisturizing effect Effects 0.000 abstract description 6
- 241000037740 Coptis chinensis Species 0.000 abstract description 5
- 230000036541 health Effects 0.000 abstract description 4
- 230000001914 calming effect Effects 0.000 abstract description 3
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 26
- 230000000694 effects Effects 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 18
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 17
- 241000555676 Malassezia Species 0.000 description 15
- 230000005764 inhibitory process Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000002994 raw material Substances 0.000 description 10
- 239000000523 sample Substances 0.000 description 8
- 230000003385 bacteriostatic effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 244000303965 Cyamopsis psoralioides Species 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- OYINQIKIQCNQOX-UHFFFAOYSA-M 2-hydroxybutyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCC(O)C[N+](C)(C)C OYINQIKIQCNQOX-UHFFFAOYSA-M 0.000 description 3
- 244000082872 Alchemilla vulgaris Species 0.000 description 3
- 235000000008 Alchemilla vulgaris Nutrition 0.000 description 3
- 241000555688 Malassezia furfur Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000009513 Coptidis rhizoma extract Substances 0.000 description 2
- 240000008892 Helianthus tuberosus Species 0.000 description 2
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 1
- 244000286838 Eclipta prostrata Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 241000218093 Phedimus aizoon Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- XYHOBCMEDLZUMP-UHFFFAOYSA-N coptisine Chemical compound C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 XYHOBCMEDLZUMP-UHFFFAOYSA-N 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- QKQCPXJIOJLHAL-UHFFFAOYSA-L disodium;2-[2-(carboxylatomethoxy)ethyl-[2-(dodecanoylamino)ethyl]amino]acetate Chemical compound [Na+].[Na+].CCCCCCCCCCCC(=O)NCCN(CC([O-])=O)CCOCC([O-])=O QKQCPXJIOJLHAL-UHFFFAOYSA-L 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- HVFAVOFILADWEZ-UHFFFAOYSA-M sodium;2-[2-(dodecanoylamino)ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCCN(CCO)CC([O-])=O HVFAVOFILADWEZ-UHFFFAOYSA-M 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
The invention provides an anti-dandruff composition, application of the anti-dandruff composition, shampoo and a preparation method of the shampoo, wherein the anti-dandruff composition comprises a coptis extract, a sedum pinnatum extract and inulin; the anti-dandruff composition disclosed by the invention adopts an anti-dandruff thought with the advantages of combining bacteriostasis and oil control and combining short-acting and long-acting anti-dandruff, realizes quick anti-dandruff by utilizing the bacteriostasis of the coptis chinensis extract and the calming and anti-inflammatory action of the collard extract, enhances and consolidates the anti-dandruff result by utilizing the oil control action of the collard extract and the moisturizing action of inulin, improves the oil-water balance and scalp health, realizes long-acting anti-dandruff of scalp, and reduces rebound.
Description
Technical Field
The invention relates to the field of daily chemicals, and particularly relates to an anti-dandruff composition, application of the anti-dandruff composition, shampoo and a preparation method of the shampoo.
Background
The scurf is a thing which greatly influences the image of people, no one likes to have the scurf on the head of the person, but many people have the experience of long scurf regardless of the wish and the reluctance. Dandruff is produced by three major factors: vigorous oil secretion, excessive proliferation of malassezia, and individual susceptibility (weak skin barrier). In addition, various internal or external factors such as chemical factors, physical factors, microorganisms, and irritants may further contribute to the generation of dandruff. Therefore, the dandruff problem is a complex comprehensive problem and is often periodic, persistent and repetitive, but the mainstream dandruff removing thought in the market at present is to inhibit the proliferation of malassezia, and various chemical bacteriostatic agents are used for the purpose, so that although the dandruff problem can be effectively improved, the dandruff problem is easy to repeat, and the scalp can be stimulated by long-term use, so that other scalp problems can be caused. Therefore, it is necessary to find a safe and mild method for removing dandruff that does not rebound easily.
Accordingly, the prior art is yet to be improved and developed.
Disclosure of Invention
The invention mainly aims to provide an anti-dandruff composition which is milder in anti-dandruff effect and is not easy to rebound, application of the anti-dandruff composition, shampoo and a preparation method of the shampoo.
In a first aspect, the present invention provides an anti-dandruff composition comprising the following components: coptis extract, sedum pinnatum extract and inulin.
The mechanism of action of the anti-dandruff composition of the invention is as follows: the coptis extract can effectively inhibit various harmful fungi causing dandruff such as malassezia; the collard extract can regulate sebum secretion, astringe and control oil, improve oil-water balance of scalp, cut off the survival condition of malassezia from the source, and simultaneously can calm and resist inflammation, and reduce skin injury caused by inflammation; inulin has moisture retention property, can promote the growth of beneficial bacteria, and is beneficial to improving and maintaining scalp health, thereby enhancing the resistance of scalp to external stimulation; the three components have synergistic effect, so that the shampoo can quickly and effectively inhibit bacteria and remove dandruff, can achieve water-oil balance of scalp through oil control and moisture retention, and achieves the effect of maintaining scalp health and long-acting dandruff removal.
In an alternative embodiment of the first aspect of the present invention, the coptis extract is 0.1-10 parts, the collard extract is 0.1-5 parts, and the inulin is 0.1-5 parts in the composition, by weight. Preferably, the coptis extract is 1-5 parts, the collard extract is 0.5-2 parts, and the inulin is 0.5-2 parts.
In a second aspect, the invention discloses an application of the anti-dandruff composition in the preparation of hair products, wherein the hair products comprise scalp care products or hair cleaning products, the scalp care products comprise scalp essence, hair conditioner and hair mask, and the hair cleaning products comprise shampoo.
In an alternative embodiment of the second aspect of the present invention, the composition is added to the hair product in an amount of, in weight percent: the coptis extract is 0.1-10%, the collard extract is 0.1-5%, and the inulin is 0.1-5%. Preferably, the coptis extract is 1-5%, the collard extract is 0.5-2%, and the inulin is 0.5-2%.
The third aspect of the invention provides shampoo, which comprises the following components in percentage by weight: 10-30% of surfactant, 0.1-10% of hair conditioner, 0.01-1% of preservative, 0-2% of pH regulator, 0-2% of aromatic, 0.1-10% of coptis extract, 0.1-5% of collard extract, 0.1-5% of inulin, 0-10% of thickening agent and a proper amount of water.
In an alternative embodiment of the third aspect of the present invention, the surfactant comprises sodium laureth sulfate, ammonium laureth sulfate, sodium laureth-6 carboxylate, disodium laureth sulfosuccinate, sodium C14-16 olefin sulfonate, sodium lauroyl glutamate, disodium lauroyl glutamate, TEA lauroyl glutamate, sodium cocoyl glutamate, disodium cocoyl glutamate, TEA cocoyl glutamate, sodium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium myristoyl sarcosinate, sodium methylcocoyl taurate, sodium cocoyl propionate, potassium cocoyl hydrolyzed oat protein, lauryl betaine, cocoyl betaine, lauryl hydroxysultaine, cocoyl hydroxysultaine, One or more of cocamidopropyl betaine, sodium lauroamphoacetate, sodium cocoamphoacetate, disodium lauroamphodiacetate, disodium cocoamphodiacetate, decyl glucoside, lauryl glucoside, and cocoglucoside. Preferably, the surfactant is selected from sodium laureth sulfate and cocamidopropyl betaine.
In an alternative embodiment of the third aspect of the present invention, the hair conditioner comprises polyquaternium-7, polyquaternium-10, polyquaternium-22, polyquaternium-39, polyquaternium-47, polyquaternium-53, polyquaternium-67, polyquaternium-73, polyquaternium-74, guar hydroxypropyltrimonium chloride, hydroxypropyl guar hydroxypropyltrimonium chloride, one or more of stearamidopropyl dimethylamine, polydimethylsiloxane, dimethiconol, amodimethicone, PPG-3 octyl ether, C12-13 alcohol lactate, PEG-7 glyceryl cocoate, glyceryl laurate, PPG-14 butyl ether, di (PPG-2 myristyl polyether-10) adipate, caprylic/capric triglyceride. Preferably, the hair conditioner is selected from hydroxypropyl guar hydroxypropyl trimonium chloride.
In an alternative embodiment of the third aspect of the present invention, the pH adjusting agent is selected from one or more of citric acid, sodium citrate, sodium hydroxide, potassium hydroxide, triethanolamine, aminomethyl propanol, arginine; the thickening agent comprises one or more of PEG-150 distearate, PEG-120 methyl glucose dioleate, hydroxypropyl methyl cellulose, acrylic acid/C10-30 alkanol acrylate crosspolymer, acrylic acid copolymer, carbomer, cocamide methyl MEA, cocamide DEA and sodium chloride. Preferably, the pH regulator is citric acid; the thickening agent is selected from cocoamide methyl MEA and sodium chloride; the thickening agent is selected from cocamide methyl MEA and sodium chloride.
In an alternative embodiment of the third aspect of the invention, the preservative comprises one or more of methylchloroisothiazolinone, methylisothiazolinone, DMDM hydantoin, bis (hydroxymethyl) imidazolidinyl urea, dichlorobenzyl alcohol, potassium sorbate, chlorphenesin, phenoxyethanol, sodium benzoate, benzyl alcohol, ethylhexylglycerin, methylparaben, 1, 2-hexanediol. Preferably, the preservative is selected from phenoxyethanol and sodium benzoate.
The invention provides a preparation method of shampoo, which comprises the following steps:
adding water into an emulsifying pot, heating to 75-85 ℃, adding sodium laureth sulfate and cocamidopropyl betaine, and stirring until the sodium laureth sulfate and the cocamidopropyl betaine are completely dissolved;
adding hydroxypropyl guar hydroxypropyl trimethyl ammonium chloride, and stirring;
cooling to 45 deg.C, adding coconut oil amide methyl MEA, sodium benzoate, phenoxyethanol, citric acid, and essence, and stirring;
then adding the coptis extract, the sedum pinnatum extract and the inulin, and uniformly stirring;
and finally adding sodium chloride to adjust the viscosity, stirring for 20-30 minutes, filtering and discharging to obtain the shampoo.
Compared with the prior art, the hair product prepared from the anti-dandruff composition has the following beneficial effects:
1. the mild plant extract coptis chinensis extract is used as an anti-dandruff agent, so that excessive reproduction of malassezia is inhibited, and irritation to scalp is reduced;
2. the coptis chinensis extract, the eclipta alba extract and the inulin are mutually matched, so that the anti-dandruff effect is effectively improved;
3. the bacteriostasis and oil control are combined, and the short-acting effect and the long-acting anti-dandruff effect are combined. The invention can rapidly improve the conditions of much scurf and itching of the head by utilizing the antibacterial action of the coptis extract and the calming and anti-inflammatory action of the sedum pinnatum extract; meanwhile, by utilizing the oil control function of the collard extract and the moisturizing function of the inulin, the dandruff removing effect can be enhanced and consolidated, the oil-water balance and the scalp health are improved, and the long-acting dandruff removal of the scalp is realized.
Drawings
FIG. 1 is a graph showing the comparison of the diameters of inhibition rings obtained by the inhibition test of Malassezia with the shampoos of examples 1,2, 3, 4 and 5 of the present invention and the shampoo of comparative example 5;
FIG. 2 is a graph showing the comparison of the diameters of inhibition rings obtained by the inhibition test of Malassezia with the shampoo of example 1 and the shampoos of comparative examples 1,2, 3, 4, 5, and 6.
FIG. 3 is a graph showing a comparison of average dandruff scores obtained from consumer tests after using shampoo of example 1 of the present invention, shampoo of comparative examples 1,2, 3 and commercial shampoo.
Detailed Description
The invention provides an anti-dandruff composition, application of the anti-dandruff composition, shampoo and a preparation method thereof, and the invention is further described in detail below in order to make the purpose, technical scheme and effect of the invention clearer and clearer. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
Effect verification experiment: comprises an in-vitro antibacterial performance test, a scalp oil control test, a scalp moisturizing effect test and an anti-dandruff effect test evaluation.
In the following examples and comparative examples of the invention: all the raw material components are commercial products, wherein the COPTIS extract is purchased from Guangzhou Pinyin Biotechnology Co., Ltd, the INCI name is COPTIS (Coptis CHINENSIS) root extract, the extract contains various active alkaloids such as coptisine and berberine, has the effects of resisting bacteria and diminishing inflammation, and has antibacterial activity on various floras such as malassezia furfur and staphylococcus aureus. The extract of Alchemilla vulgaris is obtained from Active concentrates of America, INCI name is Alchemilla vulgaris (ALCHEMILLA VULGARIS) extract, contains many Active ingredients such as tannic acid, salicylic acid, saponin, phytosterol and flavonoid such as quercetin, and has effects of regulating sebum secretion, astringing, controlling oil, calming, and relieving inflammation. The INULIN is purchased from Guangzhou Tinglan Biotechnology Limited company, is called INULIN (INULIN) by INCI name, is rich in Jerusalem artichoke (Helianthus tuberosus) and Chicory (Chicoriy), is a natural water-soluble biological polysaccharide, can reduce the inhibition effect of a preservative on skin beneficial bacteria, promotes the growth of the beneficial bacteria, is beneficial to repairing or enhancing the skin microbial barrier, and plays a role in protecting and moisturizing.
In the following examples and comparative examples of the present invention, shampoo was prepared as follows (if the weight percentage of the ingredients is zero, the material is not added in the following preparation method):
s1: adding water into an emulsifying pot, heating to 75-85 deg.C, adding sodium laureth sulfate and cocamidopropyl betaine, and stirring to dissolve completely;
s2: adding hydroxypropyl guar hydroxypropyl trimethyl ammonium chloride, stirring for about 30 minutes until uniformly mixing;
s3: cooling to 45 deg.C, adding coconut oil amide methyl MEA, sodium benzoate, phenoxyethanol, citric acid, and essence, and stirring;
s4: adding the anti-dandruff composition of rhizoma Coptidis extract, herba Alchemiae Yunnanensis extract and inulin, and stirring;
s5: adding sodium chloride to adjust viscosity, stirring for 15-30 min, filtering and discharging.
Effect verification experiment of the present invention a total of 13 examples and 6 comparative examples were constructed:
the compositions of the raw material components in the shampoo formulations of the 13 examples are shown in table 1 below: (unit is% by weight)
TABLE 1
The composition of the raw material components in the shampoo formulations of the 6 comparative examples are shown in table 2 below: (unit is% by weight)
TABLE 2
In vitro bacteriostasis test:
and (3) detecting the bacteriostatic effect by adopting a bacteriostatic ring method: the culture medium is agar medium, and the test strain is malassezia furfur standard strain.
Test samples: examples 1,2, 3, 4, 5 and comparative example 5
The experimental contents are as follows:
1. malassezia furfur is prepared into bacterial suspension of about 105 cfu.
2. Evenly spread on a Leeming & Notman culture medium plate, and then placed in a sterile operating platform to blow dry bacterial liquid on the plate.
3. Quantitatively adding each shampoo composition sample into the flat plate, culturing in a 30 ℃ constant temperature incubator for 5-7 days, observing the result, and recording and measuring the bacteriostatic ring condition.
The experimental results are as follows:
the results are reported as the diameter of the zone of inhibition, in units: and (4) millimeter.
The results were judged according to the national committee for standardization of clinical trials (NCCLS) standard: the diameter of the inhibition zone is less sensitive than 8mm, the diameter of the inhibition zone is low sensitive to 8-13 mm, the diameter of the inhibition zone is moderate sensitive to 13-19 mm, and the diameter of the inhibition zone is high sensitive to 19 mm.
Fig. 1 is a data comparison graph of the size of the diameter of a bacteriostatic ring obtained by performing a bacteriostatic test on malassezia with shampoo prepared under different additive amounts of coptis chinensis extract. As can be seen from FIG. 1, the Coptidis rhizoma extract has inhibitory effect on Malassezia, and the inhibitory effect is continuously enhanced with the increase of the addition amount of the extract; when the addition amount of the coptis extract reaches 5%, the bacteriostatic effect is equivalent to that of the case of 10%, and the diameter of a bacteriostatic zone reaches 16mm, so that the coptis extract with the addition amount of 5% has a good inhibitory effect on malassezia.
Wherein, fig. 2 is a data comparison graph of the size of the diameter of the inhibition ring of the shampoo prepared from the composition of the invention by using a single raw material (comparative examples 1, 4 and 6), two raw material combinations (comparative examples 2, 3 and 5) and 3 raw material combinations (example 1) to carry out the inhibition test on malassezia.
As can be seen from the results of FIG. 2, when 3 raw materials of the composition act alone, only the Coptidis rhizoma extract has inhibitory effect on Malassezia; after the 3 raw materials are combined in various ways, only the composition containing the coptis extract is effective, and the effect of inhibiting the malassezia by the coptis extract is not obviously enhanced by the addition of the other two raw materials in the composition only from the view point of inhibiting the malassezia.
Scalp oil control test:
adopting a DZCP-04-01 skin elasticity tester (skin elasticity test probe + skin oil test probe): the scalp oil content was tested by a Cutomer dual & Sebumeter (MPA580& SM 815).
Test samples: examples 1, 6, 7, 8, 9 and comparative example 3
The test method comprises the following steps: the subjects were rested for 30 minutes in a laboratory at 22 + -3 deg.C and 50 + -5% relative humidity, scalp oil content was tested using a DZCP-04-01 skin elasticity tester, 3 mean values were measured and reported as D0 data, samples were distributed to each subject, shampooed once a day for 28 days, and skin oil content was tested in a thermostated laboratory on days 7, 14 and 28, respectively, and reported as D7, D14 and D28. The oil content change rates of D7, D14 and D28 are respectively calculated according to the following formulas:
the rate of change in fat content { (fat content after use sample-fat content before use sample)/fat content before use sample } × 100%
The experimental results are as follows:
the number of each group of subjects is 10, the data results are averaged, and the oil control effect test data of the collard extract are shown in the following table 3.
TABLE 3
From the above table 3, it can be found that the larger the addition amount is, the better the oil control effect of the sedum aizoon extract on the scalp is; and when the addition amount of the collard extract is more than or equal to 1%, the oil control effect is obvious, and when the addition amount of the collard extract reaches 2%, the addition amount is continuously increased, and the oil control effect is not obviously enhanced.
Scalp moisturizing effect test:
skin moisture content test Probe (instrument software CK-MPA-Multi-Probe-AdapterFB): corneometer CM825 tests scalp stratum corneum moisture.
Test samples: examples 1, 10, 11, 12, 13 and comparative example 2
The test method comprises the following steps: subjects sit still for 30 minutes in a laboratory at a temperature of 22 + -3 deg.C and a relative humidity of 50 + -5%, measure scalp moisture content using a skin moisture content tester, measure 5 averages, and record the data as D0, distribute the samples to each subject, wash their hair once a day for 28 days, and return to the constant temperature laboratory on days 7, 14, and 28, respectively, to measure skin moisture content, which is recorded as D7, D14, and D28.
The experimental results are as follows:
the number of the subjects in each group is 10, the data results are averaged, and the data of the inulin moisturizing effect test are shown in the following table 4.
TABLE 4
Test sample | D0/C.U. | D7/C.U. | D14/C.U. | D28/C.U. |
Comparative example 2 (0%) | 27.15 | 28.03 | 27.92 | 28.26 |
Example 13 (0.1%) | 29.43 | 30.31 | 29.97 | 30.49 |
Example 12 (0.5%) | 28.92 | 29.94 | 30.72 | 32.15 |
Example 1 (1%) | 26.53 | 28.72 | 33.74 | 36.40 |
Example 11 (2%) | 25.74 | 28.60 | 33.38 | 36.11 |
Example 10 (5%) | 27.58 | 30.57 | 35.41 | 37.97 |
As can be seen from the data in Table 4 above, the moisture retention effect of inulin is positively correlated with the addition amount, the greater the addition amount of inulin, the better the moisture retention effect, and when the addition amount is 0.1-1%, the moisture content of scalp is obviously improved, and then the moisture content of scalp is gradually increased by continuously increasing the amount of inulin.
Evaluation of the anti-dandruff effect test:
test samples: comparative examples 1,2 and 3, example 1 and a commercial anti-dandruff shampoo (Qingyang anti-dandruff shampoo for men)
The test method comprises the following steps: 50 subjects with severe dandruff symptoms and hair diseases such as silver scurf and the like between 18 and 50 years of age are selected. Subjects were scored for dandruff using a5 point scale (1 point: no dandruff; 2 points: mild; 3 points: moderate; 4 points: severe; 5 points: very severe). After the subjects received the samples, the test samples were applied every 2 days for 6 weeks (42 days) for dandruff assessment at 0, 10, 21, and 42 days; after 3 weeks (21 days) the product was discontinued and further dandruff was assessed at day 63.
The experimental results are as follows:
the number of subjects in each group was 10, and the score was averaged as shown in FIG. 3.
In this test, the higher the average dandruff score, the more severe the dandruff condition is on behalf of the consumer. As can be seen from FIG. 3, the average dandruff score of consumers using the anti-dandruff composition of example 1 and the commercial samples decreased significantly during the product trial period (D0-D42), indicating that the anti-dandruff effect of the shampoo containing the anti-dandruff composition according to the present invention can reach a level equivalent to that of the commercial products, and after 10 days of use, the dandruff condition of consumers can be improved significantly;
when the consumer deactivates the product for a period of time, it can be seen by comparing the data in fig. 3 (D63) after the sample was used for 63 days that the dandruff condition of the consumer using the commercial product showed a significant rebound, whereas the dandruff condition of the consumer using the shampoo of the present invention showed no significant rebound.
In addition, as can be seen from the combination of fig. 3 and fig. 2, in the anti-dandruff composition according to the present invention, the collard extract and the inulin do not greatly contribute to the malassezia inhibition effect of the coptis extract, but in practical applications, the combination of the two raw materials and the coptis extract not only can significantly improve the anti-dandruff effect, but also can greatly improve the problem of dandruff recurrence, and achieve long-acting anti-dandruff effect.
As described above, the above examples and comparative examples are only intended to illustrate the technical solution of the present invention, not to limit it; although the present invention has been described in detail with reference to the foregoing examples and comparative examples, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments and comparative examples can be modified or some technical features can be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments and comparative examples of the present invention.
Claims (10)
1. An anti-dandruff composition, comprising the following components: coptis extract, sedum pinnatum extract and inulin.
2. The anti-dandruff composition according to claim 1, wherein the amount of the coptis extract, the lupulus extract and the inulin is 0.1 to 10 parts by weight, 0.1 to 5 parts by weight and 0.1 to 5 parts by weight, respectively.
3. Use of an anti-dandruff composition according to claim 1 or 2 in the preparation of a hair product comprising a scalp care product comprising scalp essence, a hair conditioner, a hair film, or a hair cleansing product comprising a shampoo.
4. The use according to claim 3, wherein the composition is added to the hair product in an amount, in weight percent: the coptis extract is 0.1-10%, the collard extract is 0.1-5%, and the inulin is 0.1-5%.
5. The shampoo is characterized by comprising the following components in percentage by weight: 10-30% of surfactant, 0.1-10% of hair conditioner, 0.01-1% of preservative, 0-2% of pH regulator, 0-2% of aromatic, 0.1-10% of coptis extract, 0.1-5% of collard extract, 0.1-5% of inulin, 0-10% of thickening agent and a proper amount of water.
6. The shampoo of claim 5 wherein the surfactant comprises sodium laureth sulfate, ammonium laureth sulfate, sodium laureth-6 carboxylate, disodium laureth sulfosuccinate, sodium C14-16 olefin sulfonate, sodium lauroyl glutamate, disodium lauroyl glutamate, TEA lauroyl glutamate, sodium cocoyl glutamate, disodium cocoyl glutamate, TEA cocoyl glutamate, sodium lauroyl sarcosinate, sodium cocoyl sarcosinate, sodium myristoyl sarcosinate, sodium methylcocoyl taurate, sodium cocoyl aminopropionate, potassium cocoyl hydrolyzed oat protein, lauryl betaine, cocoyl betaine, lauryl hydroxysultaine, cocoyl hydroxysultaine, sodium cocoyl taurate, sodium cocoyl glutamate, sodium cocoyl taurate, sodium cocoyl sulfate, sodium cocoyl hydroxysultaine, One or more of cocamidopropyl betaine, sodium lauroamphoacetate, sodium cocoamphoacetate, disodium lauroamphodiacetate, disodium cocoamphodiacetate, decyl glucoside, lauryl glucoside, and cocoglucoside.
7. The shampoo according to claim 5, the hair conditioner comprises one or more of polyquaternium-7, polyquaternium-10, polyquaternium-22, polyquaternium-39, polyquaternium-47, polyquaternium-53, polyquaternium-67, polyquaternium-73, polyquaternium-74, guar hydroxypropyl trimethyl ammonium chloride, hydroxypropyl guar hydroxypropyl trimethyl ammonium chloride, stearamidopropyl dimethylamine, polydimethylsiloxane, dimethiconol, amodimethicone, PPG-3 octyl ether, C12-13 alcohol lactate, PEG-7 glyceryl cocoate, glyceryl laurate, PPG-14 butyl ether, di (PPG-2 myristyl polyether-10) adipate and caprylic/capric triglyceride.
8. The shampoo according to claim 5, wherein the pH regulator is selected from one or more of citric acid, sodium citrate, sodium hydroxide, potassium hydroxide, triethanolamine, aminomethyl propanol, arginine; the thickening agent comprises one or more of PEG-150 distearate, PEG-120 methyl glucose dioleate, hydroxypropyl methyl cellulose, acrylic acid/C10-30 alkanol acrylate crosspolymer, acrylic acid copolymer, carbomer, cocamide methyl MEA, cocamide DEA and sodium chloride.
9. The shampoo of claim 5 wherein the preservative comprises one or more of methylchloroisothiazolinone, methylisothiazolinone, DMDM hydantoin, bis (hydroxymethyl) imidazolidinyl urea, dichlorobenzyl alcohol, potassium sorbate, chlorphenesin, phenoxyethanol, sodium benzoate, benzyl alcohol, ethylhexylglycerin, methylparaben, 1, 2-hexanediol.
10. The preparation method of the shampoo is characterized by comprising the following steps:
adding water into an emulsifying pot, heating to 75-85 ℃, adding sodium laureth sulfate and cocamidopropyl betaine, and stirring until the sodium laureth sulfate and the cocamidopropyl betaine are completely dissolved;
adding hydroxypropyl guar hydroxypropyl trimethyl ammonium chloride, and stirring;
cooling to 45 deg.C, adding cocamidomethyl MEA, sodium benzoate, phenoxyethanol, citric acid, and essence, and stirring;
then adding the coptis extract, the sedum pinnatum extract and the inulin, and uniformly stirring;
and finally adding sodium chloride to adjust the viscosity, stirring for 20-30 minutes, filtering and discharging to obtain the shampoo.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210418946.4A CN114796047A (en) | 2022-04-20 | 2022-04-20 | Anti-dandruff composition, application of anti-dandruff composition, shampoo and preparation method of shampoo |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210418946.4A CN114796047A (en) | 2022-04-20 | 2022-04-20 | Anti-dandruff composition, application of anti-dandruff composition, shampoo and preparation method of shampoo |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114796047A true CN114796047A (en) | 2022-07-29 |
Family
ID=82505383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210418946.4A Pending CN114796047A (en) | 2022-04-20 | 2022-04-20 | Anti-dandruff composition, application of anti-dandruff composition, shampoo and preparation method of shampoo |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114796047A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115737484A (en) * | 2022-11-21 | 2023-03-07 | 媞颂日化用品(广州)有限公司 | Bionic hair care composition with repairing effect and application thereof |
CN116270351A (en) * | 2023-03-27 | 2023-06-23 | 仁和全域(上海)大健康研究院有限公司 | Oil-control cleansing composition and preparation method and application thereof |
CN117462463A (en) * | 2023-10-26 | 2024-01-30 | 广东泛华生物科技有限公司 | Composition with scalp anti-dandruff effect and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120038585A (en) * | 2010-10-14 | 2012-04-24 | 배정빈 | Oriental medicine extract for prevention of alopecia and hair article composition |
CN107149579A (en) * | 2017-05-18 | 2017-09-12 | 广东芭薇生物科技股份有限公司 | A kind of creams for pressing down acne effect plant composition containing oil-control |
CN107260626A (en) * | 2017-05-25 | 2017-10-20 | 珀莱雅化妆品股份有限公司 | A kind of composition with long-acting moisture-keeping function and preparation method thereof |
CN107412045A (en) * | 2017-05-19 | 2017-12-01 | 广州蜜妆生物科技有限公司 | A kind of prebiotics is good for skin facial mask |
CN110227048A (en) * | 2019-07-22 | 2019-09-13 | 广州好迪集团有限公司 | Efficient anti-dandruff and itching-relieving shampoo, hair lotion and hair film |
CN114028292A (en) * | 2021-12-06 | 2022-02-11 | 广州市发歌精细化工有限公司 | Shampoo containing plant composite anti-dandruff agent and preparation method thereof |
-
2022
- 2022-04-20 CN CN202210418946.4A patent/CN114796047A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120038585A (en) * | 2010-10-14 | 2012-04-24 | 배정빈 | Oriental medicine extract for prevention of alopecia and hair article composition |
CN107149579A (en) * | 2017-05-18 | 2017-09-12 | 广东芭薇生物科技股份有限公司 | A kind of creams for pressing down acne effect plant composition containing oil-control |
CN107412045A (en) * | 2017-05-19 | 2017-12-01 | 广州蜜妆生物科技有限公司 | A kind of prebiotics is good for skin facial mask |
CN107260626A (en) * | 2017-05-25 | 2017-10-20 | 珀莱雅化妆品股份有限公司 | A kind of composition with long-acting moisture-keeping function and preparation method thereof |
CN110227048A (en) * | 2019-07-22 | 2019-09-13 | 广州好迪集团有限公司 | Efficient anti-dandruff and itching-relieving shampoo, hair lotion and hair film |
CN114028292A (en) * | 2021-12-06 | 2022-02-11 | 广州市发歌精细化工有限公司 | Shampoo containing plant composite anti-dandruff agent and preparation method thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115737484A (en) * | 2022-11-21 | 2023-03-07 | 媞颂日化用品(广州)有限公司 | Bionic hair care composition with repairing effect and application thereof |
CN116270351A (en) * | 2023-03-27 | 2023-06-23 | 仁和全域(上海)大健康研究院有限公司 | Oil-control cleansing composition and preparation method and application thereof |
CN117462463A (en) * | 2023-10-26 | 2024-01-30 | 广东泛华生物科技有限公司 | Composition with scalp anti-dandruff effect and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114796047A (en) | Anti-dandruff composition, application of anti-dandruff composition, shampoo and preparation method of shampoo | |
US11998767B2 (en) | Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines | |
CN110934783B (en) | Dandruff-removing and itching-relieving composition containing Chinese herbal medicines, silicone oil-free amino acid shampoo containing composition, and preparation method and application of silicone oil-free amino acid shampoo | |
CN112656732B (en) | Dandruff-removing and itching-relieving shampoo and preparation method thereof | |
CN113440449A (en) | Anti-dandruff composition and application thereof | |
CN114533586A (en) | Dandruff-removing itching-relieving shampoo composition, and preparation method and application thereof | |
CN108670878B (en) | Cosmetic composition for resisting skin allergy | |
EP3648732B1 (en) | Topical compositions | |
CN108324591B (en) | A hair composition containing marine bioactive substances | |
CN111012730A (en) | Composition for regulating scalp microecology | |
CN115813841B (en) | Anti-dandruff itching-relieving composition, preparation method and application thereof, shampoo and preparation method | |
CN108815084A (en) | A kind of dandruff control shampoo containing and preparation method thereof containing Herba Lophatheri extract | |
WO2024149410A1 (en) | Anti-dandruff use of dihydroartemisinin | |
CN110755331A (en) | Antibacterial infant washing and caring preparation and application thereof | |
CN113230184A (en) | Scalp composition for 1+1 scalp hair cleaning and preparation method thereof | |
CN114366702B (en) | Shampoo with effects of removing dandruff, relieving itching and controlling oil and preparation method thereof | |
CN114533647A (en) | Silicon oil-free anti-dandruff shampoo composition and preparation method thereof | |
CN115607463A (en) | Composition for preventing or treating scalp seborrheic dermatitis and application thereof | |
CN112891252A (en) | Mild itching-relieving bath composition and preparation method thereof | |
CN112076111B (en) | Dandruff-removing shampoo composition | |
CN112156060A (en) | Propolis wash-free long-acting antibacterial gel and preparation method thereof | |
CN114366693B (en) | Shampoo bath lotion for infants | |
CN115177546B (en) | Non-irritating high-efficiency anti-dandruff composition and anti-dandruff shampoo | |
CN115624507A (en) | Mild bacteriostatic agent and preparation method and application thereof | |
CN112426391B (en) | Chitosan nourishing and skin moistening shower gel and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220729 |